Aprogen Medicines Market Cap

Aprogen Medicines has a market cap or net worth of 97.81 billion as of March 9, 2026. Its market cap has decreased by -52.46% in one year.

Market Cap

97.81B

Enterprise Value

551.38B

Revenue

126.09B

Ranking

n/a

PE Ratio

n/a

Stock Price

317.00

Market Cap Chart

Since December 7, 1995, Aprogen Medicines's market cap has increased from 19.56B to 97.81B, an increase of 400.05%. That is a compound annual growth rate of 5.46%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	103.98B	-51.65%
Dec 30, 2025	215.06B	-2.20%
Dec 30, 2024	219.89B	-6.16%
Dec 28, 2023	234.32B	-41.38%
Dec 27, 2022	399.71B	19.11%
Dec 30, 2021	335.57B	-10.30%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
HLB GLOBAL	96.40B
Singsong Holdings	75.53B
Gridwiz	139.87B
Woongjin	149.14B
JLK, Inc.	174.91B
HS HYOSUNG	196.43B
Ocean In W	33.26B
KPX Holdings	298.14B

Market Cap Rankings